Autopsy report · NCT03071809

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

“Accrual difficulties”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 1 year 9 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Lexent Bio, Inc.

Sponsor type

Industry

Conditions

Neoplasms, Non-hematologic - Stage I-III

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
  “Poor accrual” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.